West Pharmaceutical Services WST Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's free cash flow yield?
- West Pharmaceutical Services (WST) reported free cash flow yield of 2.5% in Q1 2026.
- How has West Pharmaceutical Services's free cash flow yield changed year-over-year?
- West Pharmaceutical Services's free cash flow yield increased by 33.7% year-over-year, from 1.9% to 2.5%.
- What is the long-term trend for West Pharmaceutical Services's free cash flow yield?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's free cash flow yield has grown at a 16.6% compound annual growth rate (CAGR), from 4.6% to 8.4%.
- What does free cash flow yield mean?
- The spendable cash the business throws off each year as a percentage of its market price.
- How do you interpret free cash flow yield?
- Higher yield can mean better value — you pay less for each dollar of cash generated. A useful sanity check against earnings-based multiples, which non-cash items can distort.
- How does free cash flow yield compare across companies?
- Comparable across cash-generative companies; less meaningful for firms in heavy-investment phases with temporarily negative FCF.